Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (22)

2024

  1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Extracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques

    PLoS ONE, Vol. 18, Núm. 4 April

  4. Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?

    Frontiers in Medicine, Vol. 10

  5. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19

    International Journal of COPD, Vol. 18, pp. 2473-2481

  6. Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study

    Microorganisms, Vol. 11, Núm. 11

  7. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors

    Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82

2022

  1. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  2. The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 6, pp. 1075-1085

2020

  1. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 56, Núm. 9, pp. 551-558

  2. Q Fever (Coxiella Burnetii)

    Seminars in Respiratory and Critical Care Medicine, Vol. 41, Núm. 4, pp. 509-521

2014

  1. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 10, pp. 2693-2701

2010

  1. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia

    Journal of Infection, Vol. 60, Núm. 2, pp. 106-113

2009

  1. Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia

    Thorax, Vol. 64, Núm. 6, pp. 496-501

2006

  1. Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency

    Archivos de Bronconeumologia, Vol. 42, Núm. 12, pp. 645-659

2004

  1. Drug-resistant pneumococcal pneumonia: Clinical relevance and related factors

    Clinical Infectious Diseases, Vol. 38, Núm. 6, pp. 787-798